←
Paul Pfeffer1,123 posts
Paul Pfeffer avatar

Paul Pfeffer

@DoctorPfeff

Respiratory Dr with interest in asthma and airways immunology, personalised medicine and effects of the environment. Also coffee, comedies and music.

◷ Joined January 2014▧ 60 Photos and videos
ERS publications avatar
⟳ Paul Pfeffer retweeted
ERS publications@ERSpublications·Jun 1

ERJ Open Research: Young adults with severe asthma experience disproportionately poor outcomes despite specialist care, highlighting the need for age-appropriate personalised management bit.ly/3KiSIaS

Post attachment
@SBHRLHRespEd avatar
⟳ Paul Pfeffer retweeted
@SBHRLHRespEd@SbhRlhRespEd·Feb 23

This week's question was written by Prof Paul Pfeffer, who is an Asthma specialist at Bart's Hospital. Answers to come Friday!

Post attachment
ERS publications avatar
⟳ Paul Pfeffer retweeted
ERS publications@ERSpublications·Jan 24

ERJOR: Severe asthma biologics are effective in a broad range of patients, including those not meeting the inclusion/exclusion criteria for phase 3 RCTs, although noninferiority could not be shown for those RCT-ineligible by poor medication adherence bit.ly/40ZL8a8

Post attachment
Paul Pfeffer avatar
Paul Pfeffer@DoctorPfeff·29 Jul 2025

Clear association between frequent SABA use and acute cardiovascular events in both patients with asthma/COPD and those without. Salbutamol is not a benign medication that can be taken excessively without any risks. dovepress.com/association-of…

Paul Pfeffer avatar
Paul Pfeffer@DoctorPfeff·29 Jul 2025

Great to see our new paper out showing the cardiovascular dangers from high SABA blue reliever use. And our recent research on implementing SABA-free management. @QMULBartsTheLon @opri_sg linkedin.com/feed/update/urn…